Evidence map›Paper›PMID 37310793›Full record

ArticleJCI insight2023

Leishmania major drives host phagocyte death and cell-to-cell transfer depending on intracellular pathogen proliferation rate.

Iris Baars, Moritz Jaedtka, Leon-Alexander Dewitz, Yan Fu, Tobias Franz, Juliane Mohr, Patricia Gintschel, Hannes Berlin, Angelina Degen, Sandra Freier and 5 more

Open access · goldAbstract read
In one paragraph

Article in JCI insight, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Leishmaniasis.Nature reviews. Disease primers · 2025
    Review
  4. Review
  5. An inclusive assessment of apoptosis mechanisms inCurrent research in parasitology & vector-borne diseases · 2025
    Review
  6. Article
  7. Review
  8. Frontiers in immunology · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 2 countries.

Iris BaarsExperimental Immunodynamics, Institute of Molecular and Clinical Immunology, Medical Faculty, and.
Moritz JaedtkaDivision of Immunology, Paul Ehrlich Institute, Langen, Germany.
Leon-Alexander DewitzExperimental Immunodynamics, Institute of Molecular and Clinical Immunology, Medical Faculty, and.
Yan FuExperimental Immunodynamics, Institute of Molecular and Clinical Immunology, Medical Faculty, and.
Tobias FranzHealth Campus Immunology, Infectiology and Inflammation (GCI3), Medical Faculty and Center for Health and Medical Prevention (CHaMP), Otto von Guericke University Magdeburg, Magdeburg, Germany.
Juliane MohrHealth Campus Immunology, Infectiology and Inflammation (GCI3), Medical Faculty and Center for Health and Medical Prevention (CHaMP), Otto von Guericke University Magdeburg, Magdeburg, Germany.
Patricia GintschelExperimental Immunodynamics, Institute of Molecular and Clinical Immunology, Medical Faculty, and.
Hannes BerlinExperimental Immunodynamics, Institute of Molecular and Clinical Immunology, Medical Faculty, and.
Angelina DegenExperimental Immunodynamics, Institute of Molecular and Clinical Immunology, Medical Faculty, and.
Sandra FreierExperimental Immunodynamics, Institute of Molecular and Clinical Immunology, Medical Faculty, and.
Stefan RygolExperimental Immunodynamics, Institute of Molecular and Clinical Immunology, Medical Faculty, and.
Burkhart SchravenHealth Campus Immunology, Infectiology and Inflammation (GCI3), Medical Faculty and Center for Health and Medical Prevention (CHaMP), Otto von Guericke University Magdeburg, Magdeburg, Germany.
Sascha KahlfußHealth Campus Immunology, Infectiology and Inflammation (GCI3), Medical Faculty and Center for Health and Medical Prevention (CHaMP), Otto von Guericke University Magdeburg, Magdeburg, Germany.
Ger van ZandbergenDivision of Immunology, Paul Ehrlich Institute, Langen, Germany.
Andreas J MüllerExperimental Immunodynamics, Institute of Molecular and Clinical Immunology, Medical Faculty, and.
Institute of Immunology · HROtto-von-Guericke-Universität Magdeburg · DEJohannes Gutenberg University Mainz · DEHelmholtz Centre for Infection Research · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The virulence of intracellular pathogens relies largely on the ability to survive and replicate within phagocytes but also on release and transfer into new host cells. Such cell-to-cell transfer could represent a target for counteracting microbial pathogenesis. However, our understanding of the underlying cellular and molecular processes remains woefully insufficient. Using intravital 2-photon microscopy of caspase-3 activation in the Leishmania major-infected (L. major-infected) live skin, we showed increased apoptosis in cells infected by the parasite. Also, transfer of the parasite to new host cells occurred directly without a detectable extracellular state and was associated with concomitant uptake of cellular material from the original host cell. These in vivo findings were fully recapitulated in infections of isolated human phagocytes. Furthermore, we observed that high pathogen proliferation increased cell death in infected cells, and long-term residency within an infected host cell was only possible for slowly proliferating parasites. Our results therefore suggest that L. major drives its own dissemination to new phagocytes by inducing host cell death in a proliferation-dependent manner.

Indexed as

ApoptosisLeishmania majorPhagocytesAnimalsCells, CulturedHumansMiceMice, Inbred C57BLVirulenceApoptosisInfectious diseaseMacrophagesMicrobiologyMonocytes

Identifiers

PMID37310793
PMCPMC10443809
OpenAlexW4380538022

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.